methyllidocaine

SynDRA canonical compound SYN0062717 — structure-anchored drug synonym record

Clinical phase	Preclinical
Mechanism of action	antiarrhythmic medication

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

CYP2D6
OPRK1
APEX1
CYP2C19
CYP2C9
CYP3A4
OPRD1
OPRM1
TSHR

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

CP2CJ
CP2D6

Drug classes

antiarrhythmic medication

Cross-references

PubChem CID: 168868
ChEMBL: CHEMBL1550996
ChEBI: 93054
LINCS BRD: BRD-K60060639

Synonyms

N-methyllidocaine-iodide
[2-(2,6-Dimethylanilino)-2-oxoethyl]-diethyl-methylammonium
[2-(2,6-dimethylanilino)-2-oxoethyl]-diethyl-methylazanium
Tocris-1042
CBDivE_014131
SCHEMBL13073528
CHEBI:93054
AKOS025150623
NCGC00024959-01
AB00074221-01
BRD-K60060639-005-01-4
BRD-K60060639-005-02-2
[2-(2,6-dimethylanilino)-2-oxoethyl]-diethyl-methylammonium

Look up methyllidocaine in the interactive SynDRA portal →